Enliven Therapeutics ELVN
$46.53 +$0.12 (+0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $46.53 0.00%
Open$46.05
Prev close$46.41
Day range$45.64 – $47.83
Volume933.6K
Market cap$3.42B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts10
Average target$74.88+60.9% vs. price
- Buy 100%
Low $70.00Now $46.53Avg $74.88High $82.00
Recent rating changes
The last 20 actions on file set price targets from $68.00 to $82.00, averaging $74.25.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | H.C. Wainwright | BUY | $73.00 |
| 6 Nov 2026 | JonesTrading | BUY | $70.00 |
| 6 Nov 2026 | Guggenheim | BUY | $78.00 |
| 5 Nov 2026 | Stifel | BUY | $82.00 |
| 5 Nov 2026 | Barclays | BUY | $78.00 |
| 19 Oct 2026 | H.C. Wainwright | BUY | $73.00 |
| 7 Oct 2026 | TD Cowen | BUY | – |
| 7 Oct 2026 | Barclays | BUY | $78.00 |
| 6 Oct 2026 | William Blair | BUY | – |
| 5 Oct 2026 | Morgan Stanley | BUY | $70.00 |
| 2 Oct 2026 | Morgan Stanley | BUY | $70.00 |
| 1 Oct 2026 | J.P. Morgan | BUY | $75.00 |
| 22 Aug 2026 | William Blair | BUY | – |
| 18 Aug 2026 | William Blair | BUY | – |
| 18 Aug 2026 | Barclays | BUY | $78.00 |
| 17 Aug 2026 | Mizuho Securities | BUY | $73.00 |
| 13 Aug 2026 | Stifel | BUY | $82.00 |
| 8 Aug 2026 | LifeSci Capital | BUY | $70.00 |
| 7 Aug 2026 | LifeSci Capital | BUY | $70.00 |
| 6 Aug 2026 | Clear Street | BUY | $68.00 |
No comments yet — be the first to weigh in on ELVN.
Sign in to join the discussion.